Stereotactic body radiation therapy for oligometastases

References

• The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J. Thorac. Cardiovasc. Surg.113(1), 37–49 (1997).
   PubMed Web of Science ®Google Scholar
• HellmanS, Weichselbaum RR. Oligometastases. J. Clin. Oncol.13(1), 8–10 (1995).
   PubMed Web of Science ®Google Scholar
• Mehta N, Mauer AM, Hellman S et al. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int. J. Oncol.25(6), 1677–1683 (2004).
   PubMed Web of Science ®Google Scholar
• Fong, Cohen AM, Fortner JG et al. Liver resection for colorectal metastases. J. Clin. Oncol.15(3), 938–946 (1997).
   PubMed Web of Science ®Google Scholar
• Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg.230(3), 309–318 (1999).
   PubMed Web of Science ®Google Scholar
• Miller G, Biernacki P, Kemeny NE et al. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases. J. Am. Coll. Surg.205(2), 231–238 (2007).
   PubMedGoogle Scholar
• Shah SA, Haddad R, Al-Sukhni W et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J. Am. Coll. Surg.202(3), 468–475 (2006).
   PubMed Web of Science ®Google Scholar
• Patchell RA, Tibbs PA, Regine WF et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet366(9486), 643–648 (2005).
   PubMed Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Papiez L et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Expert Rev. Anticancer Ther.8(1), 87–98 (2008).
   PubMed Web of Science ®Google Scholar
• Lo SS, Cardenes HR, Teh BS et al. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev. Anticancer Ther.8(12), 1939–1951 (2008).
   PubMed Web of Science ®Google Scholar
• Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am. J. Clin. Oncol.30(6), 637–644 (2007).
   PubMed Web of Science ®Google Scholar
• Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.70(3), 847–852 (2008).
   PubMed Web of Science ®Google Scholar
• Wang JZ, Mayr NA, Yuh WTC. A generalized linear–qudratic formula for high-dose-rate brachytherapy and radiosurgery. Int. J. Radiat. Oncol. Biol. Phys.69(3 Suppl.), S619–S620 (2007).
   PubMedGoogle Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol.34(6), 861–870 (1995).
   PubMed Web of Science ®Google Scholar
• Uematsu M, Shioda A, Tahara K et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer82(6), 1062–1070 (1998).
   PubMed Web of Science ®Google Scholar
• Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int. J. Radiat. Oncol. Biol. Phys.48(2), 449–457 (2000).
   PubMed Web of Science ®Google Scholar
• Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R. Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther. Onkol.177(12), 645–655 (2001).
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int. J. Radiat. Oncol. Biol. Phys.60(1), 186–196 (2004).
   PubMed Web of Science ®Google Scholar
• Hof H, Hoess A, Oetzel D, Debus J, Herfarth K. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther. Onkol.183(12), 673–678 (2007).
   PubMed Web of Science ®Google Scholar
• Lee SW, Choi EK, Park HJ et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer40(3), 309–315 (2003).
   PubMed Web of Science ®Google Scholar
• Okunieff P, Petersen AL, Philip A et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol.45(7), 808–817 (2006).
   PubMed Web of Science ®Google Scholar
• Hara R, Itami J, Kondo T et al. Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother. Oncol.63(2), 159–163 (2002).
   PubMedGoogle Scholar
• Nagata Y, Negoro Y, Aoki T et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int. J. Radiat. Oncol. Biol. Phys.52(4), 1041–1046 (2002).
   PubMed Web of Science ®Google Scholar
• Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int. J. Radiat. Oncol. Biol. Phys.72(2), 398–403 (2008).
   PubMed Web of Science ®Google Scholar
• Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a Phase I/II study. Strahlenther. Onkol.182(12), 696–702 (2006).
   PubMedGoogle Scholar
• Whyte RI, Crownover R, Murphy MJ et al. Stereotactic radiosurgery for lung tumors: preliminary report of a Phase I trial. Ann. Thorac. Surg.75(4), 1097–1101 (2003).
   PubMed Web of Science ®Google Scholar
• Le QT, Loo BW, Ho A et al. Results of a Phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J. Thorac. Oncol.1(8), 802–809 (2006).
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin. Radiat. Oncol.16(2), 77–84 (2006).
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Goranson H et al. Radiosurgery for tumors in the body: clinical experience using a new method. J. Radiosurg.1(1), 63–74 (1998).
   Google Scholar
• Sato M, Uematsu M, Yamamoto F. Feasiblity of frameless stereotactic high-dose radiaiton therapy for primary and metastatic liver cancer. J. Radiosurg.1, 233–238 (1998).
   Google Scholar
• Wada H, Takai Y, Nemoto K, Yamada S. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int. J. Radiat. Oncol. Biol. Phys.58(4), 1114–1120 (2004).
   PubMedGoogle Scholar
• Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: results of a Phase I/II trial. J. Clin. Oncol.19(1), 164–170 (2001).
   PubMed Web of Science ®Google Scholar
• Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int. J. Radiat. Oncol. Biol. Phys.67(3), 793–798 (2007).
   PubMed Web of Science ®Google Scholar
• Gunven P, Blomgren H, Lax I, Levitt SH. Curative stereotactic body radiotherapy for liver malignancy. Med. Oncol. (2008) (Epub ahead of print).
   Google Scholar
• Mendez Romero A, Wunderink W, Hussain SM et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study. Acta Oncol., 45(7), 831–837 (2006).
   PubMed Web of Science ®Google Scholar
• Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A Phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int. J. Radiat. Oncol. Biol. Phys.62(5), 1371–1378 (2005).
   PubMed Web of Science ®Google Scholar
• Kavanagh BD, Schefter TE, Cardenes HR et al. Interim analysis of a prospective Phase I/II trial of SBRT for liver metastases. Acta Oncol.45(7), 848–855 (2006).
   PubMed Web of Science ®Google Scholar
• Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother. Oncol.52(2), 111–121 (1999).
   PubMed Web of Science ®Google Scholar
• Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother. Oncol.6(4), 247–255 (1986).
   PubMed Web of Science ®Google Scholar
• Steenland E, Leer JW, van Houwelingen H et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother. Oncol.52(2), 101–109 (1999).
   PubMed Web of Science ®Google Scholar
• Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative radiotherapy trials for bone metastases: a systematic review. J. Clin. Oncol.25(11), 1423–1436 (2007).
   PubMed Web of Science ®Google Scholar
• Ryu S, Fang Yin F, Rock J et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer97(8), 2013–2018 (2003).
   PubMed Web of Science ®Google Scholar
• Ryu S, Rock J, Rosenblum M, Kim JH. Patterns of failure after single-dose radiosurgery for spinal metastasis. J. Neurosurg.101(Suppl. 3), 402–405 (2004).
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.55(1), 162–167 (2003).
   PubMedGoogle Scholar
• Hamilton AJ, Lulu BA, Fosmire H, Stea B, Cassady JR. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery36(2), 311–319 (1995).
   PubMed Web of Science ®Google Scholar
• Mahan SL, Ramsey CR, Scaperoth DD, Chase DJ, Byrne TE. Evaluation of image-guided helical tomotherapy for the retreatment of spinal metastasis. Int. J. Radiat. Oncol. Biol. Phys.63(5), 1576–1583 (2005).
   PubMed Web of Science ®Google Scholar
• Rock JP, Ryu S, Shukairy MS et al. Postoperative radiosurgery for malignant spinal tumors. Neurosurgery58(5), 891–898 (2006).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ. Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. J. Neurosurg. Spine3(4), 296–301 (2005).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine32(2), 193–199 (2007).
   PubMed Web of Science ®Google Scholar
• Gibbs IC, Kamnerdsupaphon P, Ryu MR et al. Image-guided robotic radiosurgery for spinal metastases. Radiother. Oncol.82(2), 185–190 (2007).
   PubMed Web of Science ®Google Scholar
• Yamada Y, Lovelock DM, Yenice KM et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys.62(1), 53–61 (2005).
   PubMed Web of Science ®Google Scholar
• Chang EL, Shiu AS, Mendel E et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J. Neurosurg. Spine7(2), 151–160 (2007).
   PubMed Web of Science ®Google Scholar
• Sahgal A, Chuang C, Larson D. Proximity of spinous/paraspinous radiosurgery metastatic targets to the spinal cord versus risk of local failure. Int. J. Radiat. Oncol. Biol. Phys.69, S243 (2007).
   Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C et al. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J. Neurosurg. Spine3(4), 288–295 (2005).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Quinn AE, Agarwala SS, Kirkwood JM. Radiosurgery for the treatment of spinal melanoma metastases. Stereotact. Funct. Neurosurg.83(5–6), 213–221 (2005).
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Welch WC et al. Single-fraction radiosurgery for the treatment of spinal breast metastases. Cancer104(10), 2244–2254 (2005).
   PubMed Web of Science ®Google Scholar
• Sahgal A, Larson DA, Chang EL. Stereotactic body radiosurgery for spinal metastases: a critical review. Int. J. Radiat. Oncol. Biol. Phys.71(3), 652–665 (2008).
   PubMed Web of Science ®Google Scholar
• Chang EL, Shiu AS, Lii MF et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys.59(5), 1288–1294 (2004).
   PubMed Web of Science ®Google Scholar
• Cerfolio RJ, Allen MS, Deschamps C et al. Pulmonary resection of metastatic renal cell carcinoma. Ann. Thorac. Surg.57(2), 339–344 (1994).
   PubMed Web of Science ®Google Scholar
• Fourquier P, Regnard JF, Rea S, Levi JF, Levasseur P. Lung metastases of renal cell carcinoma: results of surgical resection. Eur. J. Cardiothorac. Surg.11(1), 17–21 (1997).
   PubMedGoogle Scholar
• Lo SS, Chang EL, Suh JH. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev. Neurother.5(4), 487–495 (2005).
   PubMedGoogle Scholar
• Brown PD, Brown CA, Pollock BE, Gorman DA, Foote RL. Stereotactic radiosurgery for patients with “radioresistant” brain metastases. Neurosurgery62(Suppl. 2), 790–801 (2008).
   PubMedGoogle Scholar
• Chang EL, Selek U, Hassenbusch SJ 3rd et al. Outcome variation among “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery56(5), 936–945 (2005).
   PubMedGoogle Scholar
• Teh BS, Bloch C, Paulino AC et al. Pathologic complete response in renal cell carcinoma brain metastases treated with stereotactic radiosurgery. Clin. Genitourin. Cancer5(5), 334–337 (2007).
   PubMedGoogle Scholar
• Wersall PJ, Blomgren H, Lax I et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother. Oncol.77(1), 88–95 (2005).
   PubMed Web of Science ®Google Scholar
• Svedman C, Sandstrom P, Pisa P et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol.45(7), 870–875 (2006).
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Traberg Hansen A et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol.45(7), 823–830 (2006).
   PubMed Web of Science ®Google Scholar
• Salama JK, Chmura SJ, Mehta N et al. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin. Cancer Res.14(16), 5255–5259 (2008).
   PubMedGoogle Scholar
• Milano MT, Katz AW, Muhs AG et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer112(3), 650–658 (2008).
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int. J. Radiat. Oncol. Biol. Phys.63(4), 1010–1015 (2005).
   PubMed Web of Science ®Google Scholar
• Timmerman R, McGarry R, Yiannoutsos C et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J. Clin. Oncol.24(30), 4833–4839 (2006).
   PubMed Web of Science ®Google Scholar
• Ryu S, Jin JY, Jin R et al. Partial volume tolerance of the spinal cord and complications of single-dose radiosurgery. Cancer109(3), 628–636 (2007).
   PubMed Web of Science ®Google Scholar
• Laufer I, Rose P, Lis E, Bilsky MH, Yamada Y. An analysis of risk factors for vertebral body fracture following high-dose single-fraction image-guided intensity modulated radiotherapy (IG IMRT) of spinal metastases. Int. J. Radiat. Oncol. Biol. Phys.72(1 Suppl.), S52 (2008).
   Google Scholar
• McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.73(1), 112–118 (2009).
   PubMed Web of Science ®Google Scholar